Article Details
Retrieved on: 2025-03-20 19:36:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the digital design and development of nirmatrelvir/ritonavir (Paxlovid) amidst the COVID-19 pandemic. It highlights the use of predictive science tools and digital design for efficient drug development and manufacturing. The connection with the key concept 'Digital Design' lies in leveraging computational tools to optimize pharmaceutical processes, ensuring rapid drug supply and enhanced clinical outcomes. The tags relate to the components and strategies involved in the development, such as CYP3A4 inhibitors, tablet formulation, and pharmacokinetics in COVID-19 drug development.
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here